+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Flunitrazepam Market by Product Type, Formulation, Application, Distribution Channel, End User, Route of Administration, Dosage Strength - Global Forecast to 2030- Product Image
Flunitrazepam Market by Product Type, Formulation, Application, Distribution Channel, End User, Route of Administration, Dosage Strength - Global Forecast to 2030- Product Image
Sale

Flunitrazepam Market by Product Type, Formulation, Application, Distribution Channel, End User, Route of Administration, Dosage Strength - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016177
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The flunitrazepam market is navigating complex shifts, driven by evolving regulatory landscapes, innovative product developments, and increasing emphasis on safer, patient-centered therapies. Senior stakeholders face growing opportunities and challenges in a sector balancing innovation, compliance, and operational efficiency.

Market Snapshot: Flunitrazepam Market Overview

The Flunitrazepam Market grew from USD 134.22 million in 2024 to USD 140.21 million in 2025. It is expected to continue growing at a CAGR of 4.30%, reaching USD 172.79 million by 2030. This trajectory is shaped by strong demand for anxiety relief, insomnia management, and procedural sedation, compounded by regulatory scrutiny and supply chain adaptation. Commercial trends point to expanding generic options, increasingly sophisticated delivery technologies, and a rebalancing of market competition across regions. Market penetration varies by geography, influenced by healthcare access, reimbursement frameworks, and shifting patient preferences, giving rise to diversified growth strategies for participating companies.

Scope & Segmentation

This report delivers comprehensive coverage of the flunitrazepam market across core product, application, and regional categories:

  • Product Types: Generic, including branded generics and unbranded generics, and original products.
  • Formulations: Standard and orally disintegrating tablets, soft and hard gelatin capsules, solutions.
  • Applications: Anxiety relief for both generalized and situational cases, insomnia treatment subdivided into acute and chronic, and preoperative sedation for diagnostic or surgical procedures.
  • Distribution Channels: Hospital pharmacies—private and public, online pharmacies—licensed and unregulated, and retail pharmacies—chain and independent.
  • End Users: Hospitals, clinics including ambulatory surgical centers and psychiatric clinics, homecare settings with caregiver- or self-administration.
  • Route of Administration: Oral (immediate and controlled release), intravenous (bolus injection and infusion).
  • Dosage Strengths: Options include 0.5 mg, 1 mg, and 2 mg, supporting flexible regimens for diverse patient populations.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with key countries including United Kingdom, Germany, France, South Africa, Saudi Arabia, and more), and Asia-Pacific (notably China, India, Japan, Australia, Southeast Asian economies).
  • Key Companies Profiled: Hoffmann-La Roche AG, Sandoz International GmbH, Teva Pharmaceutical Industries Limited, Viatris Inc, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Apotex Inc., Krka, d. d., STADA Arzneimittel AG, Zentiva Group SE.

Key Takeaways for Decision-Makers

  • Intensified regulatory oversight has catalyzed innovation in abuse-deterrent and patient-friendly formulations, prompting reassessment of product strategies and lifecycle management.
  • Digital health platforms and telemedicine are expanding market reach and redefining patient engagement, driving new approaches to distribution and adherence monitoring.
  • Advanced analytics now play a central role in both manufacturing optimization and dynamic inventory management, enabling companies to anticipate shifts in demand and reduce supply chain risks.
  • Market segmentation reveals an ongoing pivot toward niche, high-value segments such as orodispersible and controlled-release formats tailored for specific use-cases, including geriatric or pediatric administration.
  • Strategic alliances with local distributors and contract manufacturing partners are increasingly vital to capture regional market share and navigate diverse regulatory frameworks.
  • Healthcare reforms and the rise of value-based care in established and emerging markets influence both formulary access and competitive pricing, necessitating robust evidence supporting safety and efficacy.

Tariff Impact on the Flunitrazepam Market

Recent cumulative tariffs, particularly those introduced by the United States in 2025, have restructured sourcing strategies across the flunitrazepam supply chain. Manufacturers have responded by leveraging domestic capacity or diversifying supply bases to mitigate cost increases affecting pharmaceutical inputs and packaging. Tariff adjustments have also fostered new collaborative logistics models and shaped the focus on high-margin product lines to preserve profitability under tighter margins.

Methodology & Data Sources

This analysis builds on rigorous secondary research, structured interviews with industry stakeholders, and advanced modeling to triangulate market trends. Peer-reviewed publications, regulatory filings, and patent data supported contextual insights, while expert validation ensured accuracy and timely perspectives across global markets.

Why This Report Matters

  • Equips senior executives with actionable intelligence to guide investment in product innovation, supply chain resilience, and regional partnerships within the flunitrazepam sector.
  • Delivers segmentation-driven insights that help optimize portfolio strategies and enhance competitive positioning amid evolving regulatory and market conditions.
  • Supports stakeholder alignment by integrating operational, regulatory, and commercial perspectives with scenario-based recommendations for market entry or expansion.

Conclusion

The flunitrazepam market presents diverse opportunities for agile organizations ready to adapt to regulatory, technology, and patient care developments. Access to robust analysis will empower leaders to navigate complexity and drive sustainable value creation across global markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Flunitrazepam Market, by Product Type
8.1. Introduction
8.2. Generic
8.2.1. Branded Generics
8.2.2. Unbranded Generics
8.3. Original
9. Flunitrazepam Market, by Formulation
9.1. Introduction
9.2. Capsule
9.2.1. Hard Gelatin Capsule
9.2.2. Soft Gelatin Capsule
9.3. Solution
9.4. Tablet
9.4.1. Orally Disintegrating Tablet
9.4.2. Standard Tablet
10. Flunitrazepam Market, by Application
10.1. Introduction
10.2. Anxiety Relief
10.2.1. Generalized Anxiety
10.2.2. Situational Anxiety
10.3. Insomnia Treatment
10.3.1. Acute Insomnia
10.3.2. Chronic Insomnia
10.4. Preoperative Sedation
10.4.1. Diagnostic Procedure Sedation
10.4.2. Surgical Procedure Sedation
11. Flunitrazepam Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Private Hospital Pharmacy
11.2.2. Public Hospital Pharmacy
11.3. Online Pharmacy
11.3.1. Licensed E Pharmacy
11.3.2. Unregulated Online Platform
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
12. Flunitrazepam Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Ambulatory Surgical Centers
12.2.2. Psychiatric Clinics
12.3. Homecare
12.3.1. Caregiver Administration
12.3.2. Self Administration
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
13. Flunitrazepam Market, by Route of Administration
13.1. Introduction
13.2. Intravenous
13.2.1. Bolus Injection
13.2.2. Infusion
13.3. Oral
13.3.1. Controlled Release
13.3.2. Immediate Release
14. Flunitrazepam Market, by Dosage Strength
14.1. Introduction
14.2. 0.5 Mg
14.3. 1 Mg
14.4. 2 Mg
15. Americas Flunitrazepam Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Flunitrazepam Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Flunitrazepam Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Hoffmann-La Roche AG
18.3.2. Sandoz International GmbH
18.3.3. Teva Pharmaceutical Industries Limited
18.3.4. Viatris Inc
18.3.5. Sun Pharmaceutical Industries Limited
18.3.6. Dr. Reddy’s Laboratories Limited
18.3.7. Apotex Inc.
18.3.8. Krka, d. d.
18.3.9. STADA Arzneimittel AG
18.3.10. Zentiva Group SE
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. FLUNITRAZEPAM MARKET MULTI-CURRENCY
FIGURE 2. FLUNITRAZEPAM MARKET MULTI-LANGUAGE
FIGURE 3. FLUNITRAZEPAM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FLUNITRAZEPAM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 20. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. FLUNITRAZEPAM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. FLUNITRAZEPAM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FLUNITRAZEPAM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FLUNITRAZEPAM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY BRANDED GENERICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY UNBRANDED GENERICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ORIGINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY HARD GELATIN CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY SOFT GELATIN CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY STANDARD TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY GENERALIZED ANXIETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY SITUATIONAL ANXIETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ACUTE INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY CHRONIC INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY DIAGNOSTIC PROCEDURE SEDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY SURGICAL PROCEDURE SEDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY LICENSED E PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY UNREGULATED ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PSYCHIATRIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY INFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY 0.5 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY 1 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL FLUNITRAZEPAM MARKET SIZE, BY 2 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES FLUNITRAZEPAM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 118. CANADA FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. CANADA FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 120. CANADA FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. CANADA FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 122. CANADA FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 123. CANADA FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. CANADA FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 125. CANADA FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. CANADA FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 127. CANADA FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. CANADA FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 129. CANADA FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 130. CANADA FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 131. CANADA FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. CANADA FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 133. CANADA FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 134. CANADA FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 135. CANADA FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. CANADA FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 137. CANADA FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 138. CANADA FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 139. MEXICO FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. MEXICO FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 141. MEXICO FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. MEXICO FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 143. MEXICO FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 144. MEXICO FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. MEXICO FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 146. MEXICO FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. MEXICO FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 148. MEXICO FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. MEXICO FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 150. MEXICO FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 151. MEXICO FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 152. MEXICO FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. MEXICO FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. MEXICO FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 159. MEXICO FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA FLUNITRAZEPAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 245. GERMANY FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. GERMANY FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 247. GERMANY FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. GERMANY FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 249. GERMANY FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 250. GERMANY FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. GERMANY FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 252. GERMANY FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 253. GERMANY FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 254. GERMANY FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. GERMANY FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 256. GERMANY FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 257. GERMANY FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 258. GERMANY FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. GERMANY FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 260. GERMANY FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 261. GERMANY FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 262. GERMANY FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. GERMANY FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 264. GERMANY FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 265. GERMANY FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 266. FRANCE FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. FRANCE FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 268. FRANCE FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 269. FRANCE FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 270. FRANCE FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 271. FRANCE FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. FRANCE FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 273. FRANCE FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 274. FRANCE FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 275. FRANCE FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. FRANCE FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 277. FRANCE FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 278. FRANCE FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 279. FRANCE FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. FRANCE FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 281. FRANCE FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 282. FRANCE FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 283. FRANCE FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. FRANCE FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 285. FRANCE FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 286. FRANCE FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 287. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 308. ITALY FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. ITALY FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 310. ITALY FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 311. ITALY FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 312. ITALY FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 313. ITALY FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. ITALY FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 315. ITALY FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 316. ITALY FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 317. ITALY FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. ITALY FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 319. ITALY FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 320. ITALY FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 321. ITALY FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. ITALY FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 323. ITALY FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 324. ITALY FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 325. ITALY FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 326. ITALY FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 327. ITALY FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 328. ITALY FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 329. SPAIN FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. SPAIN FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 331. SPAIN FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 332. SPAIN FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 333. SPAIN FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 334. SPAIN FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. SPAIN FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 336. SPAIN FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 337. SPAIN FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 338. SPAIN FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. SPAIN FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 340. SPAIN FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 341. SPAIN FLUNITRAZEPAM MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 342. SPAIN FLUNITRAZEPAM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. SPAIN FLUNITRAZEPAM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 344. SPAIN FLUNITRAZEPAM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 345. SPAIN FLUNITRAZEPAM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 346. SPAIN FLUNITRAZEPAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 347. SPAIN FLUNITRAZEPAM MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 348. SPAIN FLUNITRAZEPAM MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 349. SPAIN FLUNITRAZEPAM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY GENERIC, 2018-2030 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY ANXIETY RELIEF, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY INSOMNIA TREATMENT, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY PREOPERATIVE SEDATION, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES FLUNITRAZEPAM MARKET SIZE, BY RETA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Flunitrazepam market report include:
  • Hoffmann-La Roche AG
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy’s Laboratories Limited
  • Apotex Inc.
  • Krka, d. d.
  • STADA Arzneimittel AG
  • Zentiva Group SE

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 140.21 Million
Forecasted Market Value ( USD ) by 2030 $ 172.79 Million
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Flunitrazepam (CAS 1622-62-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Flunitrazepam (CAS 1622-62-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Brotizolam Market by Treatment Duration, Product Type, Distribution Channel, End User, Dosage Strength, Formulation - Global Forecast to 2030 - Product Image

Brotizolam Market by Treatment Duration, Product Type, Distribution Channel, End User, Dosage Strength, Formulation - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Flumazenil Market by Type, End User, Distribution Channel, Dosage Form, Application - Global Forecast to 2030 - Product Image

Flumazenil Market by Type, End User, Distribution Channel, Dosage Form, Application - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Benzodiazepine Drugs - Global Strategic Business Report - Product Image

Benzodiazepine Drugs - Global Strategic Business Report

  • Report
  • 388 Pages
  • Global
From
Anxiety Disorders and Depression Treatment Market Size, Share & Trends Analysis Report by Drug Type, Indication (Depression, Anxiety), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Anxiety Disorders and Depression Treatment Market Size, Share & Trends Analysis Report by Drug Type, Indication (Depression, Anxiety), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From

About the Flunitrazepam Market

Flunitrazepam is a benzodiazepine drug used as an anesthetic. It is a central nervous system depressant, and is used to induce sleep, reduce anxiety, and relax muscles. It is also used as a premedication before surgery, and is sometimes used to treat insomnia. Flunitrazepam is a Schedule IV controlled substance in the United States, and is not available for medical use in many countries. Flunitrazepam is a powerful sedative, and can cause respiratory depression, coma, and death if taken in large doses. It is also highly addictive, and can cause physical and psychological dependence. As a result, it is important to use flunitrazepam only under the supervision of a qualified medical professional. The flunitrazepam market is a small but important part of the anesthetic drugs market. It is used in a variety of medical settings, including pre-operative sedation, anesthesia, and treatment of insomnia. Some companies in the flunitrazepam market include Roche, Pfizer, Merck, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.